These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1378260)

  • 1. Assessing symptom improvement after elective prostatectomy for benign prostatic hypertrophy.
    Flood AB; Black NA; McPherson K; Smith J; Williams G
    Arch Intern Med; 1992 Jul; 152(7):1507-12. PubMed ID: 1378260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia.
    Tubaro A; Carter S; Hind A; Vicentini C; Miano L
    J Urol; 2001 Jul; 166(1):172-6. PubMed ID: 11435849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does evaluation with the International Prostate Symptom Score predict the outcome of transurethral resection of the prostate?
    Hakenberg OW; Pinnock CB; Marshall VR
    J Urol; 1997 Jul; 158(1):94-9. PubMed ID: 9186331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of the effects of prostatectomy on symptoms and quality of life.
    Derrett S; Paul C; Herbison P
    N Z Med J; 2001 Jun; 114(1134):276-9. PubMed ID: 11480508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting change in quality of life after prostatectomy for benign prostatic hypertrophy: the impact of surgical techniques.
    Mozes B; Cohen YC; Olmer L; Shabtai E
    J Urol; 1996 Jan; 155(1):191-6. PubMed ID: 7490831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urodynamic study of obstructive uropathy due to benign prostatic hyperplasia].
    Fedel V; Povrzanović I; Fedel I
    Lijec Vjesn; 1992; 114(9-12):259-61. PubMed ID: 1285282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral resection versus incision of the prostate: a randomized, prospective study.
    Riehmann M; Knes JM; Heisey D; Madsen PO; Bruskewitz RC
    Urology; 1995 May; 45(5):768-75. PubMed ID: 7538238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy.
    Javlé P; Jenkins SA; Machin DG; Parsons KF
    J Urol; 1998 Nov; 160(5):1713-7. PubMed ID: 9783938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High power potassium-titanyl-phosphate laser vaporization prostatectomy.
    Malek RS; Kuntzman RS; Barrett DM
    J Urol; 2000 Jun; 163(6):1730-3. PubMed ID: 10799170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.
    Lukacs B; Leplège A; Thibault P; Jardin A
    Urology; 1996 Nov; 48(5):731-40. PubMed ID: 8911517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity.
    Seki N; Kai N; Seguchi H; Takei M; Yamaguchi A; Naito S
    Urology; 2006 Feb; 67(2):306-10. PubMed ID: 16461081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of prostatectomy in the treatment of obstructive benign prostatic hypertrophy].
    Virseda M; Salinas J; Prieto L; Blanco E; Resel L
    Actas Urol Esp; 1992; 16(10):776-82. PubMed ID: 1283653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary tract infection associated with benign prostatic hypertrophy and related diseases and transurethral surgery].
    Okishio N; Hanai S; Ishiguro K; Yanaoka M; Tamai H; Naide Y
    Hinyokika Kiyo; 1986 Nov; 32(11):1610-6. PubMed ID: 2435126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
    Helfand B; Mouli S; Dedhia R; McVary KT
    J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral collagen injections for male intrinsic sphincter deficiency: the University of Texas-Houston experience.
    Westney OL; Bevan-Thomas R; Palmer JL; Cespedes RD; McGuire EJ
    J Urol; 2005 Sep; 174(3):994-7. PubMed ID: 16094021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nocturia quality of life before and shortly after prostatectomy.
    Margel D; Lifshitz D; Brown N; Lask D; Livne PM; Tal R
    Urology; 2007 Sep; 70(3):493-7. PubMed ID: 17905104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.